1. Home
  2. SIF vs KZIA Comparison

SIF vs KZIA Comparison

Compare SIF & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIFCO Industries Inc.

SIF

SIFCO Industries Inc.

HOLD

Current Price

$20.02

Market Cap

108.1M

Sector

Industrials

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$11.00

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIF
KZIA
Founded
1913
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.1M
100.8M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
SIF
KZIA
Price
$20.02
$11.00
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.50
AVG Volume (30 Days)
101.2K
198.4K
Earning Date
05-08-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
86.67
N/A
EPS
0.72
N/A
Revenue
$111,212,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.95
$4.86
52 Week High
$22.50
$17.40

Technical Indicators

Market Signals
Indicator
SIF
KZIA
Relative Strength Index (RSI) 57.64 45.26
Support Level $12.99 $5.71
Resistance Level $20.39 $14.57
Average True Range (ATR) 1.34 0.99
MACD -0.11 -0.30
Stochastic Oscillator 50.00 19.77

Price Performance

Historical Comparison
SIF
KZIA

About SIF SIFCO Industries Inc.

SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: